Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information - Comparable Adjustments (Details)

v3.20.4
Business Segment Information - Comparable Adjustments (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Cost of product sold        
Net gain (loss) on undesignated derivative contracts $ 11.0 $ 4.6 $ (18.4) $ (31.1)
Total cost of product sold (1,169.9) (1,011.9) (3,189.6) (3,238.5)
Selling, general, and administrative expenses        
Net gain (loss) on undesignated derivative contracts 11.0 4.6 (18.4) (31.1)
Total selling, general, and administrative expenses (463.8) (406.3) (1,211.8) (1,251.7)
Impairment of assets held for sale (21.0) (390.0) (24.0) (417.0)
Gain (loss) on sale of business (0.3) 76.0 (4.7) 76.0
Foreign currency contracts | Selling, general, and administrative expenses        
Cost of product sold        
Net gain (loss) on undesignated derivative contracts 1.9 1.5 (18.1) (7.4)
Selling, general, and administrative expenses        
Net gain (loss) on undesignated derivative contracts 1.9 1.5 (18.1) (7.4)
Comparable Adjustments        
Cost of product sold        
Recovery of (loss on) inventory write-down (26.5) 0.0 (26.5) 8.6
Strategic business development costs (0.7) (61.7) (25.8) (124.2)
COVID-19 incremental costs (0.8) 0.0 (6.3) 0.0
Flow through of inventory step-up 0.0 (0.3) (0.1) (1.5)
Accelerated depreciation 0.0 (1.8) 0.0 (7.1)
Total cost of product sold (12.3) (58.4) (28.8) (140.4)
Selling, general, and administrative expenses        
Restructuring and other strategic business development costs (12.7) (2.4) (21.6) (25.5)
Transaction, integration, and other acquisition-related costs (1.5) (1.2) (5.4) (6.7)
COVID-19 incremental costs (0.8) 0.0 (6.3) 0.0
Impairment of intangible assets 0.0 0.0 0.0 (11.0)
Other gains (losses) (4.3) 0.0 4.6 1.1
Total selling, general, and administrative expenses (18.7) (4.4) (35.2) (42.9)
Impairment of assets held for sale (21.0) (390.0) (24.0) (417.0)
Gain (loss) on sale of business (0.3) 76.0 (4.7) 76.0
Comparable Adjustments, Operating income (loss) (52.3) (376.8) (92.7) (524.3)
Gain on vineyard sale     8.8 0.0
Increase in our ownership interest in Nelson’s Green Brier     0.0 11.8
(Increase) in estimated fair value of a contingent liability associated with a prior period acquisition     0.0 (11.4)
Comparable Adjustments | Selling, general, and administrative expenses        
Cost of product sold        
COVID-19 incremental costs (0.2) 0.0 (4.8) 0.0
Selling, general, and administrative expenses        
COVID-19 incremental costs (0.2) 0.0 (4.8) 0.0
Comparable Adjustments | Commodity derivative contracts        
Cost of product sold        
Net gain (loss) on undesignated derivative contracts 9.1 3.1 (0.3) (23.7)
Settlements of undesignated commodity derivative contracts 6.6 2.3 30.2 7.5
Selling, general, and administrative expenses        
Net gain (loss) on undesignated derivative contracts 9.1 3.1 (0.3) (23.7)
Comparable Adjustments | Foreign currency contracts        
Cost of product sold        
Net gain (loss) on undesignated derivative contracts 0.0 (0.8) (8.0) (0.8)
Selling, general, and administrative expenses        
Net gain (loss) on undesignated derivative contracts $ 0.0 $ (0.8) $ (8.0) $ (0.8)